Wall Street analysts shuffled their outlooks on several notable stocks this Friday, with moves ranging from aggressive bullishness to dramatic target cuts. Here's what the pros are forecasting.
Top Analyst Forecasts: Capital One Could Rally 24% According to Wall Street
Get Agios Pharmaceuticals Alerts
Weekly insights + SMS alerts
Capital One Gets a Boost
BTIG raised its price target on Capital One Financial Corporation (COF) from $264 to $308, while analyst Vincent Caintic maintained a Buy rating. The new target implies roughly 24% upside from Wednesday's closing price of $248.27. That's the kind of potential gain that gets investors' attention, suggesting BTIG sees meaningful catalysts ahead for the financial services giant.
Agios Pharmaceuticals Draws Double Upgrades
Agios Pharmaceuticals, Inc. (AGIO) caught positive attention from two firms. HC Wainwright & Co. raised its price target substantially from $48 to $62, with analyst Emily Bodnar maintaining a Buy rating. Separately, Leerink Partners increased its target from $34 to $40, as analyst Andrew Berens kept an Outperform rating on the stock. Agios shares closed at $29.17 on Wednesday, meaning HC Wainwright's target suggests more than doubling from current levels.
Lexaria Bioscience Faces Reality Check
Not all news was rosy. HC Wainwright & Co. slashed its price target on Lexaria Bioscience Corp (LEXX) from $4 to $1.50, though analyst Yi Chen maintained a Buy rating. With shares closing at $0.56 on Wednesday, even the reduced target implies significant upside. But the dramatic 62.5% cut to the target suggests the firm is recalibrating expectations substantially lower, even while staying constructive on the stock's direction.
These analyst moves reflect the ongoing reassessment of valuations and growth prospects across different sectors, from financial services to biotechnology. Whether these targets prove accurate remains to be seen, but they offer a window into how Wall Street's research desks are thinking about these companies right now.
More News

Markets Hit New Highs Amid Ceasefire News, But Oil Jumps on Hormuz Tensions
Make This One Trade at 2:59 PM on Friday Afternoon, and you'll Thank Me Monday Morning

Operation 'Economic Fury': U.S. Unleashes Financial Firepower on Iran as Hegseth Delivers 'Choose Wisely' Ultimatum

TSMC's AI Boom: The Chip Giant Beats Forecasts and Tells Rivals There Are 'No Shortcuts'

Oil's At $90, Gas Is Over $4, But These 7 Energy Stocks Are Priced Like The Crisis Is Over
Remember Tesla?

Jensen Huang Says Nvidia Is 'Not A Car' And Its AI Dominance Isn't Going Anywhere

U.S. Bancorp Beats Earnings, But Investors Focus on Rising Credit Costs
Get Agios Pharmaceuticals Alerts
Real-time alerts on price moves, news, and trading opportunities.
Join 20,000+ investors. No spam, ever.
Featured Articles
View all news
Markets Hit New Highs Amid Ceasefire News, But Oil Jumps on Hormuz Tensions
Make This One Trade at 2:59 PM on Friday Afternoon, and you'll Thank Me Monday Morning (Ad)

Operation 'Economic Fury': U.S. Unleashes Financial Firepower on Iran as Hegseth Delivers 'Choose Wisely' Ultimatum

TSMC's AI Boom: The Chip Giant Beats Forecasts and Tells Rivals There Are 'No Shortcuts'

Oil's At $90, Gas Is Over $4, But These 7 Energy Stocks Are Priced Like The Crisis Is Over
Trump's Secret Retirement Fund (Ad)

Jensen Huang Says Nvidia Is 'Not A Car' And Its AI Dominance Isn't Going Anywhere





